Regeneron Pharmaceuticals (REGN)

Depreciation & Amortization

$528.60M

TTM · Period ending: · USD

REGN logo

REGN Depreciation & Amortization

Latest reported$528.60M
REGN TTM Depreciation & Amortization ($2.00M → $528.60M)
High-resolution chart · PNG

REGN depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
5,198,000
4,824,000
4,421,000
4,025,000
3,771,000
3,626,000
3,400,000
3,200,000
3,000,000
2,800,000
3,000,000
3,400,000
3,600,000
4,100,000
4,400,000
4,900,000
5,500,000
5,800,000
6,100,000
5,800,000
5,900,000
5,800,000
5,900,000
5,800,000
5,300,000
4,900,000
4,200,000
3,900,000
3,600,000
3,300,000
3,100,000
2,800,000
2,500,000
2,300,000
2,000,000
1,700,000
1,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.